Fremgangsmåter for å behandle psykose forbundet med glykokortikoidrelatert dysfunksjon

摘要

This invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for amelirating psychotic major depression. Mifepristone, a potent glucocorticoid receptor antagonist, can be used in these methods.